Minireview
British Journal of Cancer (2006) 94, 1559–1567. doi:10.1038/sj.bjc.6603162 www.bjcancer.com
Published online 16 May 2006
Controlled clinical trials in cancer pain. How controlled should they be? A qualitative systematic review
R F Bell1, T Wisløff2, C Eccleston3 and E Kalso4
- 1Regional Centre of Excellence in Palliative Care Western Norway/Institute for Surgical Sciences/Pain Clinic Haukeland University Hospital, N-5021 Bergen, Norway
- 2Norwegian Knowledge Centre for the Health Services, Oslo, Norway
- 3Pain Management Unit, Royal National Hospital for Rheumatic Diseases/University of Bath, UK
- 4Pain Clinic, Helsinki University Central Hospital/University of Helsinki, Finland
Correspondence: Dr RF Bell, E-mail: rae.bell@helse-bergen.no
Received 30 January 2006; Revised 4 April 2006; Accepted 10 April 2006; Published online 16 May 2006.
Abstract
This qualitative systematic review of the clinical methodology used in randomised, controlled trials of oral opioids (morphine, hydromorphone, oxycodone) for cancer pain underlines the difficulties of good pain research in palliative care. The current literature lacks placebo-controlled superiority trials. Recommendations for future research are discussed.
Keywords:
systematic review, methodology, opioids, cancer pain
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
